These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 23967248)
1. copy number variation analysis in familial BRCA1/2-negative Finnish breast and ovarian cancer. Kuusisto KM; Akinrinade O; Vihinen M; Kankuri-Tammilehto M; Laasanen SL; Schleutker J PLoS One; 2013; 8(8):e71802. PubMed ID: 23967248 [TBL] [Abstract][Full Text] [Related]
2. Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients. Silva FC; Lisboa BC; Figueiredo MC; Torrezan GT; Santos EM; Krepischi AC; Rossi BM; Achatz MI; Carraro DM BMC Med Genet; 2014 May; 15():55. PubMed ID: 24884479 [TBL] [Abstract][Full Text] [Related]
3. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067 [TBL] [Abstract][Full Text] [Related]
4. Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC). El Ansari FZ; Jouali F; Marchoudi N; Bennani MM; Ghailani NN; Barakat A; Fekkak J BMC Cancer; 2020 Aug; 20(1):747. PubMed ID: 32778078 [TBL] [Abstract][Full Text] [Related]
5. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families. Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women. Cao WM; Zheng YB; Gao Y; Ding XW; Sun Y; Huang Y; Lou CJ; Pan ZW; Peng G; Wang XJ BMC Cancer; 2019 Jun; 19(1):551. PubMed ID: 31174498 [TBL] [Abstract][Full Text] [Related]
8. Germline DNA copy number variation in familial and early-onset breast cancer. Krepischi AC; Achatz MI; Santos EM; Costa SS; Lisboa BC; Brentani H; Santos TM; Gonçalves A; Nóbrega AF; Pearson PL; Vianna-Morgante AM; Carraro DM; Brentani RR; Rosenberg C Breast Cancer Res; 2012 Feb; 14(1):R24. PubMed ID: 22314128 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition. Dos Santos ES; Caputo SM; Castera L; Gendrot M; Briaux A; Breault M; Krieger S; Rogan PK; Mucaki EJ; Burke LJ; ; Bièche I; Houdayer C; Vaur D; Stoppa-Lyonnet D; Brown MA; Lallemand F; Rouleau E Breast Cancer Res Treat; 2018 Apr; 168(2):311-325. PubMed ID: 29236234 [TBL] [Abstract][Full Text] [Related]
10. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725 [TBL] [Abstract][Full Text] [Related]
13. The role of targeted BRCA1/BRCA2 mutation analysis in hereditary breast/ovarian cancer families of Portuguese ancestry. Peixoto A; Santos C; Pinto P; Pinheiro M; Rocha P; Pinto C; Bizarro S; Veiga I; Principe AS; Maia S; Castro F; Couto R; Gouveia A; Teixeira MR Clin Genet; 2015 Jul; 88(1):41-8. PubMed ID: 24916970 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer. Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353 [TBL] [Abstract][Full Text] [Related]
15. Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals. Santonocito C; Scapaticci M; Guarino D; Bartolini A; Minucci A; Concolino P; Scambia G; Paris I; Capoluongo E Breast; 2017 Dec; 36():74-78. PubMed ID: 29020660 [TBL] [Abstract][Full Text] [Related]
16. Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan. Rashid MU; Muhammad N; Amin A; Loya A; Hamann U Breast Cancer Res Treat; 2017 Jan; 161(2):191-201. PubMed ID: 27826754 [TBL] [Abstract][Full Text] [Related]
17. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800 [TBL] [Abstract][Full Text] [Related]
18. Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients. Jarhelle E; Riise Stensland HMF; Hansen GÅM; Skarsfjord S; Jonsrud C; Ingebrigtsen M; Strømsvik N; Van Ghelue M Sci Rep; 2019 Dec; 9(1):19986. PubMed ID: 31882575 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals. Shao D; Cheng S; Guo F; Zhu C; Yuan Y; Hu K; Wang Z; Meng X; Jin X; Xiong Y; Chai X; Li H; Zhang Y; Zhang H; Liu J; Ye M Cancer Sci; 2020 Feb; 111(2):647-657. PubMed ID: 31742824 [TBL] [Abstract][Full Text] [Related]